When additional IOP reduction may be needed for a patient on PGA therapy
SIMBRINZA® Suspension should be taken at least five (5) minutes apart from other topical ophthalmic drugs.1

*Hypothetical patient
Patient Details
- Open-angle glaucoma patient with elevated IOP
- On PGA therapy that has reduced her IOP from 26 mm Hg OU to 18 mm Hg OU for several years
- Maintains an active lifestyle with an upbeat, independent attitude
Status
- Recently, Ann's IOP has risen to around 22 mm Hg OU, and optic nerve damage has progressed
- She is cognizant of the need to work toward a target IOP and a reduction of approximately 5 mm Hg
Treatment Plan
- Consider adding SIMBRINZA® Suspension to a PGA
When you want to replace a single component with a combination

*Hypothetical patient
Patient Details
- Open-angle glaucoma patient
- Currently treated with a PGA and brimonidine 0.2%
- No comorbid conditions
Status
- Joe was started on a prostaglandin 6 months ago and achieved IOP lowering
- He was later prescribed brimonidine 0.2% and obtained additional IOP control, but he still needs additional IOP reduction to reach his target IOP
- He is concerned about adding another bottle to his regimen
Treatment Plan
- Consider using SIMBRINZA® Suspension to replace Joe's brimonidine 0.2% to maintain his burden of therapy (number of bottles used per day) while offering additional IOP lowering
- Counsel Joe about lowering his IOP and give him the SIMBRINZA® Suspension QuickTip brochure
Reference: 1. SIMBRINZA® Suspension [prescribing information]. Fort Worth, TX: Alcon Laboratories Inc; 2015.